Patent Assignment
Reel/Frame 025719/0236
Assignment of Assignor's Interest
Recorded: 2011-01-31
Pages: 7
Assignor
MERCK SHARP & DOHME CORP.
Executed: 2010-10-08
Assignee
VERTEX PHARMACEUTICALS INCORPORATED
130 WAVERLY STREET, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Properties
(6)
JAK2 Tyrosine Kinase Inhibition
JAK2 Tyrosine Kinase Inhibition
Application:
12/850,920 →
Publication:
US 2010/0324063
JAK2 tyrosine kinase inhibition
Application:
60/761,724 →
JAK 2 tyrosine kinase inhibition
Application:
60/799,149 →
JAK2 tyrosine kinase inhibition
Application:
60/834,008 →
JAK2 tyrosine kinase inhibition
Application:
60/857,878 →
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
May 11, 2009
From: GILES, FRANCIS J.
To: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 022665/0088 →
Assignment of Assignor's Interest
May 11, 2009
From: POLLARD, JOHN R.
To: VERTEX PHARMACEUTICALS INCORPORATED
Reel/Frame 022665/0188 →
Assignment of Assignor's Interest
May 11, 2009
From: GIBBS, JACKSON B.; BUSER-DOEPNER, CAROLYN A.; FREEDMAN, STEVEN J.; MARSHALL, CHRISTOPHER G.
To: MERCK & CO., INC.
Reel/Frame 022665/0357 →
Assignment of Assignor's Interest
Sep 2, 2009
From: THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
To: MERCK & CO., INC.
Reel/Frame 023183/0189 →
Change of Name
Jan 26, 2010
From: MERCK & CO., INC.
To: MERCK SHARP & DOHME CORP.
Reel/Frame 023845/0940 →